← SynDRA
SECNIDAZOLE
SynDRA canonical compound SYN0016518 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | acetylcholinesterase inhibitor | microtubule inhibitor |
|---|
| Indication | protozoan infection |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- acetylcholinesterase inhibitor
- microtubule inhibitor
Drug classes
- Nitroimidazole Antimicrobial
- Anti-Infective Agents
- Antiparasitic Agents
- Antiprotozoal Agents
ATC classes
- P01A · AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
- COMBINATIONS OF ANTIBACTERIALS
Cross-references
Synonyms
- solosec
- secnidazol
- seknidazol
- flagentyl
- Secnidazol
- Ornidazole metabolite m4
- Secnidal
- Secnidazole anhydrous
- NSC-759812
- PM-185184
- RP-14539
- SYM-1219
- Deprozol
- Flagentyl
- Sabima
- Secnol
- Solosec
- Secnidazolum
- Secnidazolum [INN-Latin]
- Secnidazol [INN-Spanish]
- PM 185184;Secnidazole (Flagentyl)
- EINECS 222-134-0
- MLS000559043
- NCGC00095158-01
- SMR000149359
- 1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol
- 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
- SYM 1219
- Secnidazole (Flagentyl)
- 1-(2-Methyl-5-nitro-1-imidazolyl)-2-propanol
- NSC 759812
- 1-(2-Methyl-5-nitro-imidazol-1-yl)-propan-2-ol
- R3459K699K
- RP-14539;PM-185184
- CAS-3366-95-8
- SR-01000685111
- alpha,2-Dimethyl-5-nitro-1H-imidazole-1-ethanol
- Sindose
Reported adverse events
- Abdominal pain
- Headache
- Nausea
- Vulvovaginal candidiasis
- Vulvovaginal pruritus
Look up SECNIDAZOLE in the interactive SynDRA portal →